home / stock / mrna / mrna quote
Last: | $102 |
---|---|
Change Percent: | 0.88% |
Open: | $102.53 |
Close: | $102 |
High: | $103.505 |
Low: | $99.9 |
Volume: | 1,741,816 |
Last Trade Date Time: | 04/18/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$102 | $102.53 | $102 | $103.505 | $99.9 | 1,741,816 | 04-18-2024 |
$103.44 | $105.14 | $103.44 | $105.14 | $102.27 | 2,000,284 | 04-17-2024 |
$103.79 | $102.08 | $103.79 | $106.42 | $101.2966 | 2,164,122 | 04-16-2024 |
$103.86 | $105.02 | $103.86 | $106.2 | $102.3 | 2,273,835 | 04-15-2024 |
$105.14 | $106 | $105.14 | $107.88 | $104.65 | 2,416,804 | 04-12-2024 |
$107.01 | $107.56 | $107.01 | $108.6 | $103.68 | 3,208,650 | 04-11-2024 |
$107.14 | $107.65 | $107.14 | $110.285 | $105.9 | 3,537,391 | 04-10-2024 |
$111.6 | $105.9 | $111.6 | $115.89 | $105.78 | 8,945,993 | 04-09-2024 |
$105.09 | $102.27 | $105.09 | $105.225 | $101.06 | 2,060,119 | 04-08-2024 |
$102.88 | $101.76 | $102.88 | $103.82 | $101.05 | 2,132,169 | 04-05-2024 |
$102.27 | $102.69 | $102.27 | $105.98 | $101.72 | 3,088,009 | 04-04-2024 |
$101.21 | $103 | $101.21 | $105.15 | $97 | 5,167,815 | 04-03-2024 |
$103.61 | $104.71 | $103.61 | $105.9475 | $103.07 | 2,603,100 | 04-02-2024 |
$105.6 | $106.29 | $105.6 | $106.65 | $103.55 | 2,918,219 | 04-01-2024 |
$106.56 | $111.1 | $106.56 | $112 | $105.95 | 3,960,666 | 03-29-2024 |
$106.56 | $111.1 | $106.56 | $112 | $105.95 | 3,960,666 | 03-28-2024 |
$110.59 | $109.58 | $110.59 | $111.125 | $105.04 | 4,575,169 | 03-27-2024 |
$107.41 | $111.8 | $107.41 | $111.8 | $106.93 | 4,151,787 | 03-26-2024 |
$110.38 | $106 | $110.38 | $110.75 | $105.9 | 3,569,441 | 03-25-2024 |
$105.43 | $104.11 | $105.43 | $105.97 | $103.51 | 2,037,299 | 03-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
CAMBRIDGE, MA / ACCESSWIRE / April 17, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024 to report its first quarter 2024 financial results, and provide a corporate update. A live webcast of the call...
On Tuesday, Johnson & Johnson (NYSE: JNJ) delivered a rather mixed first quarter report. Adjusted earnings surpassed estimates&n...
2024-04-14 05:55:00 ET The bull market is roaring higher, and many growth stocks have led the gains -- but this doesn't mean your opportunity to buy growth stocks for a good price is over. Plenty of players with great long-term prospects haven't yet benefited from this favorable market envi...